These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27659548)

  • 61. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
    Comella P; Natale D; Farris A; Gambardella A; Maiorino L; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S; Cannone M
    Cancer; 2005 Jul; 104(2):282-9. PubMed ID: 15948167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
    Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T
    Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study.
    Nakayama N; Sato A; Tanaka S; Shimada K; Konishi K; Sasaki E; Hibi K; Ichikawa H; Kikuchi Y; Sakuyama T; Sekikawa T; Hayashi K; Nishina H;
    Invest New Drugs; 2015 Aug; 33(4):954-62. PubMed ID: 25937430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients.
    Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Kuijf HJ; Punt CJA; Koopman M; May AM
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):909-919. PubMed ID: 30144305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Maintenance therapy for metastatic colorectal cancer.
    Giampieri R; Cascinu S
    Lancet Oncol; 2015 Oct; 16(13):1281-2. PubMed ID: 26361970
    [No Abstract]   [Full Text] [Related]  

  • 66. First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II).
    Lurvink RJ; Rauwerdink P; Rovers KP; Wassenaar ECE; Deenen MJ; Nederend J; Huysentruyt CJR; van 't Erve I; Fijneman RJA; van der Hoeven EJRJ; Seldenrijk CA; Constantinides A; Kranenburg O; Los M; Herbschleb KH; Thijs AMJ; Creemers GM; Burger JWA; Wiezer MJ; Nienhuijs SW; Boerma D; de Hingh IHJT
    BMJ Open; 2021 Mar; 11(3):e044811. PubMed ID: 33785492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.
    Gootjes EC; van der Stok EP; Buffart TE; Bakkerus L; Labots M; Zonderhuis BM; Tuynman JB; Meijerink MR; van de Ven PM; Haasbeek CJA; Ten Tije AJ; de Groot JB; Hendriks MP; van Meerten E; Nuyttens JJME; Grunhagen DJ; Verhoef C; Verheul HMW;
    Oncologist; 2020 Aug; 25(8):e1195-e1201. PubMed ID: 32490570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Adjuvant Capecitabine and Oxaliplatin for Elderly Patients with Colorectal Cancer.
    Okamoto K; Nozawa H; Emoto S; Murono K; Sasaki K; Ishihara S
    Oncology; 2022; 100(11):576-582. PubMed ID: 36252550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice.
    Legué LM; Bernards N; Lemmens VE; de Hingh IH; Creemers GJ; van Erning FN
    United European Gastroenterol J; 2019 Dec; 7(10):1380-1388. PubMed ID: 31839964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chemotherapy of metastatic colon cancer in France: A population-based study.
    Mas L; Bachet JB; Jooste V; Lepage C; Bouvier AM
    Dig Liver Dis; 2021 Oct; 53(10):1334-1342. PubMed ID: 33865721
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study.
    Guchelaar NAD; Noordman BJ; Welten MW; van Santen MT; de Neijs MJ; Koolen SLW; Verhoeven RHA; Oomen-de Hoop E; van der Sluis PC; Lagarde SM; van Laarhoven HWM; de Hingh IHJT; Creemers GJ; Mostert B; Wijnhoven BPL; Mathijssen RHJ
    J Natl Compr Canc Netw; 2024 Jul; 22(6):405-412. PubMed ID: 39074509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in The Netherlands: a population-based study.
    Keikes L; Koopman M; Stuiver MM; Lemmens VEPP; van Oijen MGH; Punt CJA
    Acta Oncol; 2020 Apr; 59(4):395-403. PubMed ID: 32048563
    [No Abstract]   [Full Text] [Related]  

  • 73. Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients.
    Kurk SA; Stellato RK; Peeters PHM; Dorresteijn B; Jourdan M; Oskam MJ; Punt CJA; Koopman M; May AM
    Am J Clin Nutr; 2019 Dec; 110(6):1395-1403. PubMed ID: 31515555
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metastasis-Directed Radiotherapy for Oligoprogressive or Oligopersistent Metastatic Colorectal Cancer.
    Lee J; Koom WS; Byun HK; Yang G; Kim MS; Park EJ; Ahn JB; Beom SH; Kim HS; Shin SJ; Kim K; Chang JS
    Clin Colorectal Cancer; 2022 Jun; 21(2):e78-e86. PubMed ID: 34903471
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Paradigm shift from palliation to cure in metastatic microsatellite high colorectal carcinoma with immune checkpoint inhibitors.
    Dhamani AM; Sheth HS; Bhattacharyya S; Shaikh IN
    J Cancer Res Ther; 2021; 17(6):1552-1555. PubMed ID: 34916394
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy of palliative chemotherapy in elderly patients with colorectal cancer.
    Bohle W; Pachlhofer A; Zoller WG
    Z Gastroenterol; 2019 Apr; 57(4):484-490. PubMed ID: 30965378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.
    Baker K; Dunwoodie E; Jones RG; Newsham A; Johnson O; Price CP; Wolstenholme J; Leal J; McGinley P; Twelves C; Hall G
    Int J Med Inform; 2017 Jul; 103():32-41. PubMed ID: 28550999
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical characteristics and treatment propensity in elderly patients aged over 80 years with colorectal cancer.
    Jung YH; Kim JY; Jang YN; Yoo SH; Kim GH; Lee KM; Lee IK; Chung SM; Woo IS
    Korean J Intern Med; 2018 Nov; 33(6):1182-1193. PubMed ID: 29166760
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy.
    Okamoto K; Nozawa H; Sasaki K; Murono K; Emoto S; Ishihara S
    Int J Clin Oncol; 2022 Oct; 27(10):1616-1623. PubMed ID: 35867198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Chemotherapy for elderly patients with colorectal cancer].
    Takiguchi N; Soda H; Tonooka T; Denda T
    Nihon Rinsho; 2014 Jan; 72(1):139-42. PubMed ID: 24597362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.